US 11690839
Treatment of idiopathic pulmonary fibrosis
granted A61KA61K2039/505A61K31/192
Quick answer
US patent 11690839 (Treatment of idiopathic pulmonary fibrosis) held by TAKEDA GMBH expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TAKEDA GMBH
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K31/192, A61K31/4402, A61K31/4418